Syros Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2024
Amended and Restated Offer Letter, dated September 28, 2023, by and between the Registrant and Conley Chee
Syros Pharmaceuticals, Inc.
Biotechnology
2023
Form of Lock-up Agreement
Syros Pharmaceuticals, Inc.
Biotechnology
2022
Forms of Tyme Support Agreement
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Syros Support Agreement
Syros Pharmaceuticals, Inc.
Biotechnology
DE
2022
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2022
Offer Letter, effective September 27, 2021, between Syros Pharmaceuticals, Inc. and Conley Chee
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2021
Offer Letter, effective October 12, 2021, between Syros Pharmaceuticals, Inc. and Jason Haas
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2021
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2021
Letter Agreement dated November 18, 2019 by and between the Registrant and Incyte Corporation
Syros Pharmaceuticals, Inc.
Biotechnology
2020
Offer Letter dated April 24, 2013 by and between the Registrant and Eric R. Olson, Ph.D
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2020
Description of Securities Registered under Section 12 of the Exchange Act
Syros Pharmaceuticals, Inc.
Biotechnology
2020
Offer Letter effective March 12, 2018 between Syros Pharmaceuticals, Inc. and Joseph J. Ferra, Jr
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2018
Offer Letter dated November 6, 2017 by and between the Registrant and Jeremy Springhorn, Ph.D
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2018
- 1 -
Syros Pharmaceuticals, Inc.
Biotechnology
MA
2017